title: Clinical experience using intrathecal liposomal cytarabine to manage neoplastic meningitis in three patients with acute promyelocytic leukemia.
authors.forename: Rafael F
authors.initials: RF
authors.lastname: Duarte
authors.forename: Monserrat
authors.initials: M
authors.lastname: Arnan
authors.forename: Isabel
authors.initials: I
authors.lastname: Sánchez-Ortega
authors.forename: Maria Paz Queipo
authors.initials: MP
authors.lastname: de Llano
authors.forename: Pascual Fernández
authors.initials: PF
authors.lastname: Abellán
mesh_terms: D000328:Adult; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage*; D003561:Cytarabine / Q000008:administration & dosage*; D006801:Humans; D007278:Injections, Spinal; D015473:Leukemia, Promyelocytic, Acute / Q000150:complications*; D008081:Liposomes; D008297:Male; D008577:Meningeal Neoplasms / Q000188:drug therapy* / Q000209:etiology; D008581:Meningitis / Q000188:drug therapy* / Q000209:etiology
chemical_list: D000964:Antimetabolites, Antineoplastic; D008081:Liposomes; D003561:Cytarabine